277
Views
24
CrossRef citations to date
0
Altmetric
Review

Pharmacogenetics of antiarrhythmic therapy

&
Pages 1583-1590 | Published online: 28 Jul 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kaiyu Zhou, Yimin Hua, Qi Zhu, Hanmin Liu, Sen Yang, Rong Zhou & Nan Guo. (2011) Transplacental digoxin therapy for fetal tachyarrhythmia with multiple evaluation systems. The Journal of Maternal-Fetal & Neonatal Medicine 24:11, pages 1378-1383.
Read now

Articles from other publishers (23)

Ammara Siddique, Samra Bashir & Mateen Abbas. 2023. Therapeutic Approaches in Cancer Treatment. Therapeutic Approaches in Cancer Treatment 141 175 .
Soumaya El Akil, Ezohra Elouilamine, Nassima Ighid & El Hassan Izaabel. (2022) Explore the distribution of (rs35742686, rs3892097 and rs1065852) genetic polymorphisms of cytochrome P4502D6 gene in the Moroccan population. Egyptian Journal of Medical Human Genetics 23:1.
Crossref
D. Darbar. 2018. Encyclopedia of Cardiovascular Research and Medicine. Encyclopedia of Cardiovascular Research and Medicine 60 67 .
D. Darbar. 2018. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Pierre BaumannUlrich M Zanger. 2014. CYP2D6: Genetics, Pharmacology and Clinical Relevance. CYP2D6: Genetics, Pharmacology and Clinical Relevance 28 41 .
Debabrata Dash. 2014. Cardiac Arrhythmias. Cardiac Arrhythmias 345 350 .
Constanze Schmidt, Felix Wiedmann, Patrick A. Schweizer, Rüdiger Becker, Hugo A. Katus & Dierk Thomas. (2013) Class I antiarrhythmic drugs inhibit human cardiac two-pore-domain K+ (K2P) channels. European Journal of Pharmacology 721:1-3, pages 237-248.
Crossref
Ulrich M. Zanger & Matthias Schwab. (2013) Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacology & Therapeutics 138:1, pages 103-141.
Crossref
Inna Y. Gong & Richard B. Kim. (2013) Pharmacogenetic Advances in Cardiovascular Medicine: Relevance to Personalized Medicine. Current Genetic Medicine Reports 1:1, pages 1-14.
Crossref
Ulrich M. Zanger, Kathrin Klein & Jessica Rieger. 2012. Metabolism of Drugs and Other Xenobiotics. Metabolism of Drugs and Other Xenobiotics 259 284 .
Renier Myburgh, Warren E. Hochfeld, Tyren M. Dodgen, James Ker & Michael S. Pepper. (2012) Cardiovascular pharmacogenetics. Pharmacology & Therapeutics 133:3, pages 280-290.
Crossref
Gaurav Kandoi, Anjali Nanda, Vinod Scaria & Sridhar Sivasubbu. (2012) A Case for Pharmacogenomics in Management of Cardiac Arrhythmias. Indian Pacing and Electrophysiology Journal 12:2, pages 54-64.
Crossref
Alexander V. LyubimovUlrich M. Zanger. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions 1 36 .
John M. Miller & Douglas P. Zipes. 2012. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine 710 744 .
András Varró & István Baczkó. (2011) Cardiac ventricular repolarization reserve: a principle for understanding drug-related proarrhythmic risk. British Journal of Pharmacology 164:1, pages 14-36.
Crossref
Mark S. Link, Derek V. Exner, Mark Anderson, Michael Ackerman, Amin Al-Ahmad, Bradley P. Knight, Steven M. Markowitz, Elizabeth S. Kaufman, David Haines, Samuel J. Asirvatham, David J. Callans, J. Paul Mounsey, Frank Bogun, Sanjiv M. Narayan, Andrew D. Krahn, Suneet Mittal, Jagmeet Singh, John D. Fisher & Sumeet S. Chugh. (2011) HRS Policy Statement: Clinical Cardiac Electrophysiology Fellowship Curriculum: Update 2011. Heart Rhythm 8:8, pages 1340-1356.
Crossref
Li-hua HAN, Zhen-tao WANG, Hong WU, Hui-chao ZHANG, Shu-yin CHEN, Zi-jiang LONG, Hong-chao SHEN, Rui-ru LI & Sheng-wang LIANG. (2011) Effects of Lüfukang Capsules () on Coronary Artery Ligation-Induced Arrhythmia in Dogs. Journal of Traditional Chinese Medicine 31:1, pages 7-9.
Crossref
Larissa Fabritz & Paulus Kirchhof. (2010) Predictable and Less Predictable Unwanted Cardiac Drugs Effects: Individual Pre‐Disposition and Transient Precipitating Factors. Basic & Clinical Pharmacology & Toxicology 106:3, pages 263-268.
Crossref
Takeshi Aiba & Gordon F. Tomaselli. 2009. Novel Therapeutic Targets for Antiarrhythmic Drugs. Novel Therapeutic Targets for Antiarrhythmic Drugs 271 297 .
Rie Schultz Hansen, Søren-Peter Olesen, Lars Christian B Rønn & Morten Grunnet. (2008) In Vivo Effects of the IKr Agonist NS3623 on Cardiac Electrophysiology of the Guinea Pig. Journal of Cardiovascular Pharmacology 52:1, pages 35-41.
Crossref
I. Cascorbi. (2007) Pharmakogenetik in der KardiologiePharmacogenetics in cardiology. Der Kardiologe 1:4, pages 272-280.
Crossref
Diane FatkinRobyn OtwayJamie I. Vandenberg. (2007) Genes and Atrial Fibrillation. Circulation 116:7, pages 782-792.
Crossref
Paulus Kirchhof & Günter Breithardt. (2007) New concepts for old drugs to maintain sinus rhythm in patients with atrial fibrillation. Heart Rhythm 4:6, pages 790-793.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.